Compounds > 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran
Page last updated: 2024-09-03

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and sri 62-834

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran has been researched along with sri 62-834 in 1 studies

Compound Research Comparison

Studies
(2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)		Trials
(2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)		Recent Studies (post-2010)
(2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)		Studies
(sri 62-834)		Trials
(sri 62-834)		Recent Studies (post-2010) (sri 62-834)
63001600

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazill, GW; Dexter, TM1

Other Studies

1 other study(ies) available for 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and sri 62-834

ArticleYear
An antagonist to platelet activating factor counteracts the tumoricidal action of alkyl lysophospholipids.
    Biochemical pharmacology, 1989, Jan-15, Volume: 38, Issue:2

    Topics: Biological Transport; Cell Survival; Furans; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tumor Cells, Cultured

1989